Intimation of Newspaper publication as per Regulation 92 of the SEBI(ICDR) Regulations, 2018 and Regulation 30 read with Schedule lll of SEBI(LODR) Regulations, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Limited (BSE scrip code 539561) has informed the stock exchange about publishing a newspaper advertisement on May 29, 2025 regarding the completion of its Rights Issue. The company issued 49,19,400 fully paid-up equity shares of ₹1 face value at a price of ₹5.15 per share (₹4.15 premium) in the ratio of 61 rights shares for every 50 existing shares held. The company received 8,258 valid applications and allotted 47,87,90,132 rights equity shares worth about ₹47.88 crore, with shareholders contributing 41.90% and renouncees 58.07% of the total allotment. The advertisements were published in Financial Express (English), Jansatta (Hindi), and Mumbai Lakshadeep (Marathi). The credit of shares to Demat accounts and listing on BSE and NSE are expected around June 1-2, 2025.
This is a routine post-issue regulatory disclosure confirming the completion of Remedium Lifecare's Rights Issue. Shareholders who did not subscribe will see their stake diluted, while the company has raised fresh capital of about ₹47.88 crore. No immediate material price impact is expected from this announcement itself.